Sprucegrove Investment Management LTD Biogen Inc. Transaction History

Sprucegrove Investment Management LTD

$997 Million
Q2 2025

A detailed history of Sprucegrove Investment Management LTD transactions in Biogen Inc. stock. As of the latest transaction made, Sprucegrove Investment Management LTD holds 13,310 shares of BIIB stock, worth $2.13 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

13,310

Previous 14,110 5.67%

Holding current value

$2.13 Million

Previous $1.93 Million 13.42%

% of portfolio

0.17%

Previous 0.2%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$113.38 - $135.49 $90,704 - $108,392	-800 Reduced 5.67%	13,310 $1.67 Million
Q1 2025 May 13, 2025	SELL	$133.43 - $153.27 $11.2 Million - $12.8 Million	-83,745 Reduced 85.58%	14,110 $1.93 Million
Q3 2024 Oct 24, 2024	SELL	$189.07 - $236.8 $37,814 - $47,360	-200 Reduced 0.2%	97,855 $19 Million
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $228,624 - $284,064	1,200 Added 1.24%	98,055 $22.7 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $7.23 Million - $9.13 Million	34,100 Added 54.34%	96,855 $20.9 Million
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $178,072 - $214,352	800 Added 1.29%	62,755 $16.2 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $492,161 - $555,484	1,943 Added 3.24%	61,955 $15.9 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $3.13 Million - $3.62 Million	-11,388 Reduced 15.95%	60,012 $17.1 Million
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $692,712 - $789,317	2,700 Added 3.93%	71,400 $19.9 Million
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $7.02 Million - $8.53 Million	-27,800 Reduced 28.81%	68,700 $19 Million
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $14.2 Million - $19.6 Million	-73,000 Reduced 43.07%	96,500 $25.8 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $17.8 Million - $21.1 Million	-94,700 Reduced 35.84%	169,500 $34.6 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $11.5 Million - $14.5 Million	-59,300 Reduced 18.33%	264,200 $55.6 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $20 Million - $25.8 Million	89,500 Added 38.25%	323,500 $77.6 Million
Q3 2021 Nov 08, 2021	BUY	$282.99 - $369.05 $9.51 Million - $12.4 Million	33,600 Added 16.77%	234,000 $66.2 Million
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $25.1 Million - $40.2 Million	96,900 Added 93.62%	200,400 $69.4 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $25.1 Million - $29.5 Million	103,500 New	103,500 $29 Million

Others Institutions Holding BIIB

# of Institutions

1,020

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sprucegrove Investment Management LTD with notifications on news.

Account

Sprucegrove Investment Management LTD Biogen Inc. Transaction History